Division of Nephrology, Department of Medicine, University of Alabama at, Birmingham, Alabama, USA,
Veterans Affairs Medical Center, Birmingham, Alabama, USA,
Am J Nephrol. 2019;49(1):11-19. doi: 10.1159/000495261. Epub 2018 Dec 13.
Despite national vascular access guidelines promoting the use of arteriovenous fistulas (AVF) over arteriovenous grafts (AVGs) for dialysis, AVF use is substantially lower in females. We assessed clinically relevant AVF and AVG surgical outcomes in elderly male and female patients initiating hemodialysis with a central venous catheter (CVC).
Using the United States Renal Data System standard analytic files linked with Medicare claims, we assessed incident hemodialysis patients in the United States, 9,458 elderly patients (≥67 years; 4,927 males and 4,531 females) initiating hemodialysis from July 2010 to June 2011 with a catheter and had an AVF or AVG placed within 6 months. We evaluated vascular access placement, successful use for dialysis, assisted use (requiring an intervention before successful use), abandonment after successful use, and rate of interventions after successful use.
Females were less likely than males to receive an AVF (adjusted likelihood 0.57, 95% CI 0.52-0.63). Among patients receiving an AVF, females had higher adjusted likelihoods of unsuccessful AVF use (hazard ratio [HR] 1.46, 95% CI 1.36-1.56), assisted AVF use (OR 1.34, 95% CI 1.17-1.54), and AVF abandonment (HR 1.28, 95% CI 1.10-1.50), but similar relative rate of AVF interventions after successful use (relative risk [RR] 1.01, 95% CI 0.94-1.08). Among patients receiving an AVG, females had a lower likelihood of unsuccessful AVG use (HR 0.83, 95% CI 0.73-0.94), similar rates of assisted AVG use (OR 1.05, 95% CI 0.78-1.40) and AVG abandonment, and greater relative rate of interventions after successful AVG use (RR 1.16, 95% CI 1.01-1.33).
While AVFs should be considered the preferred vascular access in most circumstances, clinical AVF surgical outcomes are uniformly worse in females. Clinicians should also consider AVGs as a viable alternative in elderly female patients initiating hemodialysis with a CVC to avoid extended CVC dependence.
尽管国家血管通路指南提倡使用动静脉瘘(AVF)而非动静脉移植物(AVG)进行透析,但女性使用 AVF 的比例仍然明显较低。我们评估了在使用中心静脉导管(CVC)开始血液透析的老年男性和女性患者中,临床相关的 AVF 和 AVG 手术结局。
使用美国肾脏数据系统标准分析文件与医疗保险索赔数据进行关联,我们评估了 2010 年 7 月至 2011 年 6 月期间美国首次接受血液透析的患者,共 9458 名老年患者(≥67 岁;4927 名男性和 4531 名女性),他们使用 CVC 开始血液透析,并在 6 个月内进行了 AVF 或 AVG 置管。我们评估了血管通路的置管、用于透析的成功使用、辅助使用(在成功使用之前需要进行干预)、成功使用后的废弃以及成功使用后的干预率。
女性获得 AVF 的可能性低于男性(调整后的可能性为 0.57,95%CI 0.52-0.63)。在接受 AVF 的患者中,女性 AVF 使用不成功的调整后可能性更高(风险比[HR]1.46,95%CI 1.36-1.56)、辅助 AVF 使用(OR 1.34,95%CI 1.17-1.54)和 AVF 废弃(HR 1.28,95%CI 1.10-1.50)的可能性更高,但成功使用后的 AVF 干预相对率相似(相对风险[RR]1.01,95%CI 0.94-1.08)。在接受 AVG 的患者中,女性 AVG 使用不成功的可能性较低(HR 0.83,95%CI 0.73-0.94),辅助 AVG 使用(OR 1.05,95%CI 0.78-1.40)和 AVG 废弃的可能性相似,成功使用后的干预相对率更高(RR 1.16,95%CI 1.01-1.33)。
虽然在大多数情况下,AVF 应该被视为首选的血管通路,但女性的临床 AVF 手术结局普遍较差。临床医生在为开始使用 CVC 进行血液透析的老年女性患者选择血管通路时,也应考虑将 AVG 作为一种可行的替代方案,以避免长期依赖 CVC。